4 completed, 1 recruiting, 1 suspended, 1 terminated. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Recruiting 1, Suspended 1, Terminated 1 |
Follow Tazobactam: new trials by email Literature Review of Tazobactam trials Research Report on Tazobactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Compare the Efficacy and Safety of Extended and Intermittent Infusion of Beta-lactams in Critically Ill Paediatric Patients Extended infusion time of the following beta-lactam: meropenem, Short-term infusion time of the following beta-lactam: meropenem, Extended infusion time of the following beta-lactam: piperacillin/tazobactam - Infection, Sepsis | Phase 4 | Recruiting | Semmelweis University | 110 | 2026-09-01 | 2026-11-06 |
| BL Infusion Trial:Beta-lactam Continuous Versus Intermittent Infusion and Associated Bacterial Resistance and Therapy Outcomes in Critically Ill Patients With Severe Pneumonia Cefepime, Meropenem, or Piperacillin/Tazobactam - Pneumonia | Phase 4 | Terminated | University of Florida | 35 | 2021-12-17 | 2023-12-12 |
| Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia Piperacillin and Tazobactam for Injection, Cefepime Injection, Ceftazidime Injection - Febrile Neutropenia | Phase 4 | Completed | Murdoch Childrens Research Institute | 55 | 2021-11-15 | 2026-03-20 |
| Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae Meropenem, Ertapenem 1000 MG, Piperacillin, Tazobactam 4-0.5G Solution for Injection - Urinary Tract Infections, Enterobacteriaceae Infections | Phase 4 | Suspended | Universidad del Norte | 198 | 2019-04-01 | 2024-12-06 |
| Acute Appendicitis: Active Observation With and Without Antibiotics Antibiotic treatment (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3)., Active observation - Appendicitis | Phase 4 | Completed | Göteborg University | 126 | 2018-05-15 | 2022-08-16 |
| Optimal Care of Complicated Appendicitis Early Appendectomy, Interval Appendectomy, Antibiotics - Appendicitis, Perforated Appendicitis | Phase 4 | Completed | University of Michigan | 40 | 2017-06-29 | 2023-11-28 |
| Study Evaluation Tazocin Intervention Tazocin (pipercillin/tazobactam) - Bacterial Infections | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 134 | 2007-05-01 | 2011-04-15 |
Appendicitis (2) · Bacterial Infections (1) · Enterobacteriaceae Infections (1) · Escherichia coli Infections (1) · Febrile Neutropenia (1) · Infections (1) · Neoplasms (1) · Pneumonia (1) · Sepsis (1) · Urinary Tract Infections (1)
Göteborg University (1) · Murdoch Childrens Research Institute (1) · Semmelweis University (1) · Universidad del Norte (1) · University of Florida (1) · University of Michigan (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (2) · Australia (1) · China (1) · Colombia (1) · Hungary (1) · Sweden (1)
Andres F Estupinan Bohorquez, MD (1) · Charles Peloquin (1) · Diego F Viasus Perez, MD. PhD. (1) · Gabrielle Haeusler (1) · Kent Lundholm, Professor (1) · Steven W. Bruch, M.D. (1)